References and Notes
<A NAME="RW11205ST-1">1</A>
Gilman H.
Speeter M.
J. Am. Chem. Soc.
1943,
65:
2255
<A NAME="RW11205ST-2A">2a</A>
Singh GS.
Tetrahedron
2003,
59:
7631
<A NAME="RW11205ST-2B">2b</A>
Enantioselective Synthesis of β-Amino Acids
2nd ed.:
Juaristi E.
Soloshonok VA.
Wiley-VCH;
Hoboken:
2005.
<A NAME="RW11205ST-3A">3a</A>
Magriotis PA.
Angew. Chem. Int. Ed.
2001,
40:
4377
<A NAME="RW11205ST-3B">3b</A>
Ojima I.
Delaloge F.
Chem. Soc. Rev.
1997,
26:
377
<A NAME="RW11205ST-3C">3c</A>
Ojima I.
Acc. Chem. Res.
1995,
28:
383
<A NAME="RW11205ST-3D">3d</A>
Chemistry and Biology of β-Lactam Antibiotics
Vol. 1-3:
Morin RB.
Gorman M.
Academic Press;
New York:
1982.
<A NAME="RW11205ST-3E">3e</A>
Dürckheimer W.
Blumbach J.
Latrell R.
Scheunemann KH.
Angew. Chem., Int. Ed. Engl.
1985,
24:
180
<A NAME="RW11205ST-3F">3f</A>
Nagahara T.
Kametani T.
Heterocycles
1987,
25:
729
<A NAME="RW11205ST-3G">3g</A>
The Chemistry of β-Lactams
Page MI.
Chapman and Hall;
London:
1992.
<A NAME="RW11205ST-4A">4a</A>
Alcaide B.
Almendros P.
Curr. Med. Chem.
2004,
11:
1921
<A NAME="RW11205ST-4B">4b</A>
Deshmukh ARAS.
Bhawal BM.
Krishnaswamy D.
Govande VV.
Shinkre BA.
Jayanthi A.
Curr. Med. Chem.
2004,
11:
1889
<A NAME="RW11205ST-4C">4c</A>
Alcaide B.
Almendros P.
Synlett
2002,
381
<A NAME="RW11205ST-4D">4d</A>
Palomo C.
Aizpurua JM.
Ganboa I.
Oiarbide M.
Synlett
2001,
1813
<A NAME="RW11205ST-4E">4e</A>
Alcaide B.
Almendros P.
Chem. Soc. Rev.
2001,
30:
226
<A NAME="RW11205ST-5A">5a</A>
Hart DJ.
Ha DC.
Chem. Rev.
1989,
89:
1447
<A NAME="RW11205ST-5B">5b</A>
Chen L.
Zhao G.
Ding Y.
Tetrahedron Lett.
2003,
44:
2611
<A NAME="RW11205ST-6A">6a</A>
France S.
Weatherwax A.
Taggi AE.
Lectka T.
Acc. Chem. Res.
2004,
37:
592
<A NAME="RW11205ST-6B">6b</A>
Tomioka K.
Fujieda H.
Hayashi S.
Hussein MA.
Kambara T.
Nomura Y.
Kanai M.
Koga K.
Chem. Commun.
1999,
715
<A NAME="RW11205ST-7">7</A>
Jian SZ.
Ma C.
Wang YG.
Synthesis
2005,
725
<A NAME="RW11205ST-8">8</A>
Seki M.
Miyake T.
Izukawa T.
Ohmizu H.
Synthesis
1997,
47
<A NAME="RW11205ST-9">9</A>
Typical Procedure for the Synthesis of β-Lactams 3.
A mixture of carboximide 1 (1.0 mmol), imine 2 (1.2 mmol) and zinc dust (3 mmol) in THF (5 mL) was refluxed for 10-20 min, cooled
to r.t., poured into H2O (5 mL), and then extracted with CH2Cl2 (3 × 5 mL). The combined extracts were washed with brine, dried over anhyd Na2SO4, and evaporated in vacuo. The residue was chromatographed through a silica gel column
with hexane-EtOAc to give pure β-lactams 3 and chiral auxiliary 4.
(3
S
,4
R
)-4-(4-Chlorophenyl)-3-methyl-1-phenylazetidin-2-one (
3a): 1H NMR (500 MHz, CDCl3): δ = 1.51 (d, J = 7.4 Hz, 3 H), 3.16 (dq, J = 2.4, 7.4 Hz, 1 H, H-3), 4.61 (d, J = 2.4 Hz, 1 H, H-4), 7.06 (m, 1 H) 7.26-7.43 (m, 9 H). 13C NMR (125 MHz, CDCl3): δ = 13.35, 55.56, 62.97, 117.21, 123.99, 126.07, 128.69, 129.28, 129.38, 138.08,
138.20, 168.63. ESI-MS: m/z = 238 [M + H]+.
(3
S
,4
S
,
E
)-3-Ethyl-1-phenyl-4-styrylazetidin-2-one (
3j): 1H NMR (500 MHz, CDCl3): δ = 1.09 (t, J = 7.4 Hz, 3 H), 1.83 (m, 1 H), 1.94 (m, 1 H), 3.06 (m, 1 H, H-3), 4.33 (dd, J = 1.9, 8.4 Hz, 1 H, H-4), 6.30 (dd, J = 8.4, 15.9 Hz, 1 H), 6.78 (d, J = 15.9 Hz, 1 H), 7.03-7.50 (m, 10 H). 13C NMR (125 MHz, CDCl3): δ = 11.63, 21.85, 59.21, 60.04, 117.03, 123.93, 126.83, 127.67, 128.53, 128.95,
129.28, 133.84, 136.02, 138.56, 167.61. ESI-MS: m/z = 278 [M + H]+, 300 [M + Na]+, 577 [2 M + Na]+.
<A NAME="RW11205ST-10">10</A>
Cainelli G.
Panunzio M.
Bandini E.
Martelli G.
Spunta G.
Tetrahedron
1996,
52:
1685
<A NAME="RW11205ST-11">11</A>
CCDC 273640 contains the supplementary crystallographic data (excluding structure
factors) for compound 3b. These data can be obtained free of charge via http://www.ccdc. cam.ac.uk/conts/retrieving.html
[or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2
1EZ, UK; fax: +44(1223)336033; or deposit@ccdc.cam.ac.uk].